MRD Testing Explained in Breast Cancer: ASBrS 2025 скачать в хорошем качестве

MRD Testing Explained in Breast Cancer: ASBrS 2025

ARTICLE: https://oncologytube.com/mrd-testing-... Discover how MRD testing in breast cancer is transforming patient care with Natera’s Signatera. At ASBrS 2025, experts like Dr. Angel Rodriguez, Dr. Erica Giblin, and Dr. Alice Ho shared insights on using circulating tumor DNA (ctDNA) to detect recurrence early, optimize therapies, and personalize treatment. Learn about Signatera’s tumor-informed approach, real-world case studies, and future research from ASCO and ESMO. Timestamps: 0:00 Introduction to MRD Testing 2:15 Why MRD Matters in Breast Cancer 6:30 Signatera: How It Works 10:45 Neoadjuvant Applications 16:20 Surveillance and Early Detection 22:50 Real-World Case Studies 28:10 Challenges and Future Directions 33:40 Q&A and Closing Remarks Subscribe for more medical breakthroughs! Visit Natera’s Signatera page (https://www.natera.com/signatera) or explore hereditary cancer testing (https://www.natera.com/empower). Like, Share, Subscribe! Hit the bell for updates on cancer research and clinical topics. About OncologyTube.com: OncologyTube.com is a free video-sharing platform dedicated to oncology professionals, offering cancer research updates through videos, audio, PowerPoint presentations, and more. Visit OncologyTube.com for a detailed web post on this ASCO 2025 coverage and other oncology insights. Follow OncologyTube: eNewsletter: https://oncologytube.com/newsletter/ Twitter:   / oncologytube   LinkedIn:   / oncologytube-com   Facebook:   / oncologytube   Instagram:   / oncologytube   YouTube:    / oncologytube   Connect with Us: Share your thoughts in the comments! Join the discussion.